======= GCNT3 ======= == Gene Information == * **Official Symbol**: GCNT3 * **Official Name**: glucosaminyl (N-acetyl) transferase 3, mucin type * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9245|9245]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95395|O95395]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GCNT3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GCNT3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606836|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Glycosyltransferase that can synthesize all known mucin beta 6 N-acetylglucosaminides. Mediates core 2 and core 4 O-glycan branching, 2 important steps in mucin-type biosynthesis. Has also I-branching enzyme activity by converting linear into branched poly-N-acetyllactosaminoglycans, leading to introduce the blood group I antigen during embryonic development. {ECO:0000269|PubMed:9915862}. |Branch| |immunoglobulin production in mucosal tissue| |acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity| |N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity| |beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity| |immunoglobulin production involved in immunoglobulin mediated immune response| |mucosal immune response| |organ or tissue specific immune response| |intestinal absorption| |O-glycan processing| |digestive system process| |kidney morphogenesis| |protein O-linked glycosylation| |digestion| |immunoglobulin production| |production of molecular mediator of immune response| |immunoglobulin mediated immune response| |B cell mediated immunity| |protein glycosylation| |macromolecule glycosylation| |lymphocyte mediated immunity| |glycosylation| |kidney development| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |renal system development| |urogenital system development| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |tissue morphogenesis| |adaptive immune response| |carbohydrate derivative biosynthetic process| |Golgi membrane| |leukocyte mediated immunity| |animal organ morphogenesis| |carbohydrate derivative metabolic process| |immune effector process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |tissue development| |macromolecule biosynthetic process| |immune response| |system process| |membrane| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13122 * **Expression level (log2 read counts)**: 3.45 {{:chemogenomics:nalm6 dist.png?nolink |}}